Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Clinical trial NCT00690430 · COMPLETED

Trial details

NCT number: NCT00690430
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Refractory Resistant Carcinoid Disease

Start date: 2008-04-01
Primary completion: 2012-04-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.